SGLT2 inhibitors find that, in those who respond, there is typically a reduction in uACR of about 30% across 24 weeks
This typically causes severe belly pain, a hard belly, fever, nausea, a rapid heartbeat and general weakness
If you do experience side effects, your Nurse Practitioner in the clinic can adjust the dosing as needed
But more research is needed to know for sure
no aspiration) Johns Hopkins Arthritis Center How to give a subcutaneous injection (patient guidance) StatPearls (NCBI Bookshelf) Regular Insulin: subcutaneous administration and site rotation Immunize Canada How to Vaccinate: Best Practices (subcutaneous injection technique) Postgrad Med J (2006) Ayuk J, Sheppard MC
This is an important distinction to understand before starting treatment